CRP, D-dimer, and Comorbidities as Potential Prognostic Factors in Critically Ill COVID-19 Patients | ||
| Egyptian Journal of Cancer and Biomedical Research | ||
| Volume 8, Issue 1, March 2024, Pages 41-51 PDF (1.8 M) | ||
| Document Type: Original Article | ||
| DOI: 10.21608/jcbr.2024.264046.1335 | ||
| Authors | ||
| Mai Ibrahem salah-elden* 1; Yousry El-Sayed El-Bolkiny2; mohammed El-Sayed Hantera3; Mohammed Ali Ahmed Eid4 | ||
| 1Department of Zoology/Chemistry, Faculty of science, Tanta university, Tanta, Egypt | ||
| 2Department of Zoology, Faculty of Science, Tanta University, Egypt | ||
| 3Department of Chest Diseases, Faculty of Medicine, Tanta University, Egypt | ||
| 41-Microbiology, Botany Department, Faculty of Science, Tanta University, Egypt 2- Department of Medical Laboratory Techniques, College of Health and Medical Techniques, Al Maaqal University, Basra, Iraq | ||
| Abstract | ||
| Abstract Background: COVID-19, which is a serious disease caused by the SARS-CoV-2, has affected several countries worldwide. Most people make a full recovery but others with severe symptoms have developed ARDS. During SARS-CoV-2 infection, abnormal amounts of inflammatory mediators indicate the severity of the illness. Recognizing aberrant coagulation findings early for coagulopathy is crucial and strongly advised to help COVID-19 patients, enhance their clinical results, and lessen serious illness ,enhance their clinical outcomes, and lessen serious consequences. Aim: our objective was to evaluate the levels of plasma inflammatory agents in SARS-COV-2 patients as a prognostic factor in disease severity in Egyptians. Patients and methods: in this study, 27 hospitalized individuals with COVID-19 confirmed diagnosis were divided into several categories; 5 mild cases, 8 moderate cases,10 severe cases, and 4 critically ill cases. Additionally, there were 5 enlisted health controls. We used the multiplex ELISA technique to assess 2 plasma inflammatory mediators in all subjects and compare disease severity. Results: patients with critically ill COVID-19 have much greater levels of C-reactive protein (CRP) and D-dimer than normal controls. Patients with critically ill COVID-19 severity and prognosis have higher CRP and D-dimer and showed a strong correlation (p<0.05) with the severity of the condition elucidating D -dimer functions as a marker for prognosis in COVID-19 patients. Conclusion: Present findings reveal that CRP and D-dimer levels are promising biomarkers for COVID-19 severity, that could be used as warning indicators of COVID-19 severity and aid in its prognosis and treatment. | ||
| Keywords | ||
| SARS-COV-2; Inflammatory markers; C-Reactive Protein; D-dimer | ||
|
Statistics Article View: 99 PDF Download: 88 |
||
